Tanja Kroell
About
Tanja Kroell is a scholar working on Immunology, Oncology and Hematology.
According to data from OpenAlex, Tanja Kroell has authored 30 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 14 papers in Oncology and 11 papers in Hematology. Recurrent topics in Tanja Kroell's work include Immunotherapy and Immune Responses (21 papers), CAR-T cell therapy research (12 papers) and Immune Cell Function and Interaction (12 papers). Tanja Kroell is often cited by papers focused on Immunotherapy and Immune Responses (21 papers), CAR-T cell therapy research (12 papers) and Immune Cell Function and Interaction (12 papers). Tanja Kroell collaborates with scholars based in Germany, United States and Italy. Tanja Kroell's co-authors include Helga Schmetzer, Johanna Tischer, Christoph Schmid, Helmut R. Salih, Hans‐Jochem Kolb, R. Pelka‐Fleischer, Horst Zitzelsberger, Karin Pfister, Hans-Jochen Kölb and Christoph Schmid and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and European Journal of Cancer.
In The Last Decade
Tanja Kroell
29 papers receiving 459 citations
Peers
Tanja Kroell
Jennifer Klem United States
Aiko Matsubara Japan
Rosanna M. McEwen-Smith United Kingdom
Samuel John United States
Luis‐Alberto Pérez‐Quintero Canada
Ashley Pandolfi United States
Uwe Siegler Switzerland
Wieger J. Norde Netherlands
Soley Thordardottir Netherlands
Antonio Valeri Spain
Citations per year, relative to Tanja Kroell Tanja Kroell (= 1×)
peers
Jennifer Klem
Countries citing papers authored by Tanja Kroell
Since
Specialization
Citations
This map shows the geographic impact of Tanja Kroell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja Kroell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja Kroell more than expected).
Fields of papers citing papers by Tanja Kroell
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Tanja Kroell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja Kroell. The network helps show where Tanja Kroell may publish in the future.
Co-authorship network of co-authors of Tanja Kroell
This figure shows the co-authorship network connecting the top 25 collaborators of Tanja Kroell. A scholar is included among the top collaborators of Tanja Kroell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanja Kroell. Tanja Kroell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Kroell, Tanja, Friedhelm R. Schuster, Arndt Borkhardt, et al.. (2021). Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in ‘DC-culture-media’ shifts correlations of released chemokines with antileukemic T-cell reactions. Immunobiology. 226(3). 152088–152088.
2.
Schmohl, Joerg Uwe, Thomas Guenther, Friedhelm R. Schuster, et al.. (2020). Expression profiles of HMGB1 on B-CLL related leukocytes contribute to prediction of relapse. Immunobiology. 226(1). 152048–152048.
3.
Harabacz, I., et al.. (2018). Paramunity-inducing Factors (PINDs) in dendritic cell (DC) cultures lead to impaired antileukemic functionality of DC-stimulated T-cells. Cellular Immunology. 328. 33–48.
4.
Schmohl, Joerg Uwe, Tina Nuebling, Tanja Kroell, et al.. (2016). Expression of RANK‐L and in part of PD‐1 on blasts in patients with acute myeloid leukemia correlates with prognosis. European Journal Of Haematology. 97(6). 517–527.
5.
Schmohl, Joerg Uwe, Donato Santovito, Thomas Guenther, et al.. (2016). Expression of surface-associated 82kDa-proMMP-9 in primary acute leukemia blast cells inversely correlates with patients' risk. Experimental Hematology. 44(5). 358–362.e5.
6.
Kroell, Tanja, Friedhelm R. Schuster, Arndt Borkhardt, et al.. (2015). Cytokine Release Patterns in Mixed Lymphocyte Culture (MLC) of T-Cells with Dendritic Cells (DC) Generated from AML Blasts Contribute to Predict anti-Leukaemic T-Cell Reactions and Patients’ Response to Immunotherapy. Cell Communication & Adhesion. 22(2-6). 49–65.
7.
Kroell, Tanja, et al.. (2015). ITOC2 – 014. Immunomodulation of blasts in AML-patients (AML-pts) with clinically approved response modifiers to improve antileukemic T-cell reactivity: An ex vivo simulation of the clinical. European Journal of Cancer. 51. S5–S5.
8.
Kroell, Tanja, Doris Kraemer, Claus‐Henning Köhne, et al.. (2014). Profiles of Activation, Differentiation–Markers, or β-Integrins on T Cells Contribute to Predict T Cells’ Antileukemic Responses After Stimulation With Leukemia-derived Dendritic Cells. Journal of Immunotherapy. 37(6). 331–347.
9.
Milosevic, Slavoljub, Friedhelm R. Schuster, Tanja Kroell, et al.. (2013). CD4+ and CD8+T-cell reactions against leukemia-associated- or minor-histocompatibility-antigens in AML-patients after allogeneic SCT. Immunobiology. 219(4). 247–260.
10.
Kroell, Tanja, Doris Kraemer, Claus‐Henning Köhne, et al.. (2013). Antileukemic T-cell Responses Can Be Predicted by the Composition of Specific Regulatory T-cell Subpopulations. Journal of Immunotherapy. 36(4). 223–237.
11.
Kroell, Tanja, Andreas Hausmann, Johanna Tischer, et al.. (2012). Combined immunophenotyping and fluorescencein situhybridization with chromosome-specific DNA probes allows quantification and differentiation ofex vivogenerated dendritic cells, leukemia-derived dendritic cells and clonal leukemic cells in patients with acute myeloid leukemia. Leukemia & lymphoma. 54(6). 1297–1308.
12.
Schmetzer, Helga, Friedhelm R. Schuster, Tanja Kroell, et al.. (2012). In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotyping. Clinical and Experimental Medicine. 13(1). 29–48.
13.
Kroell, Tanja, et al.. (2010). The Quality and Quantity of Leukemia-derived Dendritic Cells From Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome Are a Predictive Factor for the Lytic Potential of Dendritic Cells-primed Leukemia-Specific T Cells. Journal of Immunotherapy. 33(5). 523–537.
14.
Kroell, Tanja, Christoph Schmid, Johanna Tischer, et al.. (2010). Dendritic Cells (DCs) Can Be Successfully Generated From Leukemic Blasts in Individual Patients With AML or MDS. Journal of Immunotherapy. 33(2). 185–199.
15.
Kroell, Tanja, Roland Reibke, Johanna Tischer, et al.. (2010). Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potential. Cellular Immunology. 265(1). 23–30.
16.
Kroell, Tanja, et al.. (2005). Expression of poliovirus receptor‐related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies. European Journal Of Haematology. 75(6). 477–484.
17.
Zitzelsberger, Horst, Tanja Kroell, R. Pelka‐Fleischer, et al.. (2005). Leukemia‐Derived Dendritic Cells can be Generated from Blood or Bone Marrow Cells from Patients with Acute Myeloid Leukaemia: A Methodological Approach under Serum‐Free Culture Conditions. Scandinavian Journal of Immunology. 62(1). 86–98.
18.
Kroell, Tanja, Christoph Schmid, Horst Zitzelsberger, et al.. (2005). Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes. Cancer Immunology Immunotherapy. 54(10). 953–970.
19.
Zitzelsberger, Horst, Tanja Kroell, R. Pelka‐Fleischer, et al.. (2005). Leukaemia‐Derived Dendritic Cells Can Be Generated From Blood or Bone Marrow Cells From Patients With Myelodysplasia: A Methodological Approach Under Serum‐Free Culture Conditions. Scandinavian Journal of Immunology. 62(1). 75–85.
20.
Pelka‐Fleischer, R., et al.. (2004). High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML). Annals of Hematology. 84(5). 287–297.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jennifer Klem Breakdown of academic impact, for papers by Aiko Matsubara Breakdown of academic impact, for papers by Rosanna M. McEwen-Smith Breakdown of academic impact, for papers by Samuel John Breakdown of academic impact, for papers by Luis‐Alberto Pérez‐Quintero Breakdown of academic impact, for papers by Ashley Pandolfi Breakdown of academic impact, for papers by Uwe Siegler Breakdown of academic impact, for papers by Wieger J. Norde Breakdown of academic impact, for papers by Soley Thordardottir Breakdown of academic impact, for papers by Antonio Valeri